BerGenBio ASA
BRRGFOTCHealthcare
$97.09
+$0.00(+0.00%)
Market Cap$9.5B
P/E Ratio—
52W High$97.09404
52W Low$0.025
BerGenBio ASA (BRRGF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BRRGF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $23.02M | $0.85M | $0.35M | $0.39M | $0.77M |
| Cost of Revenue | $87.30M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | ($64.27M) | $0.85M | $0.35M | $0.39M | $0.77M |
| Gross Margin %(computed) | -279.15% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $62.84M | $87.69M | $107.79M | $8.34M | $12.74M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $12.74M |
| Total Operating Expenses | $77.37M | $152.08M | $192.17M | $306.02M | $315.24M |
| Operating Income | ($141.65M) | ($151.23M) | ($191.82M) | ($305.63M) | ($314.46M) |
| Operating Margin %(computed) | -615.21% | — | — | — | — |
| Interest Income | $3.26M | $16.65M | $3.06M | $2.95M | $3.13M |
| Interest Expense | $0.00M | $4.70M | $0.58M | $0.32M | $0.05M |
| Income Before Tax | ($154.98M) | ($139.28M) | ($190.40M) | ($302.12M) | ($309.36M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($154.98M) | ($139.28M) | ($190.40M) | ($298.61M) | ($309.42M) |
| Net Margin %(computed) | -673.13% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-125.02 | $-11.65 | $-19.95 | $-38.65 | $-40.36 |
| Wtd Avg Shares | 1.24M | 11.96M | 9.54M | 7.73M | 7.67M |
| EBITDA | ($130.40M) | ($134.13M) | ($189.60M) | ($300.92M) | ($308.00M) |
| EBITDA Margin %(computed) | -566.38% | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · NOK · M
Explore more BerGenBio ASA data
About BerGenBio ASA (BRRGF) Income Statement
BerGenBio ASA (BRRGF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BRRGF reported revenue of $0.02B, gross profit of ($0.06B) (gross margin -279.15%), and net income of ($0.15B) — a net profit margin of -673.13%.
Frequently asked questions
BRRGF · 4 questionsBerGenBio ASA (BRRGF) reported revenue of $0.02B for 2025, up 2615.1% year-over-year.
BRRGF revenueBRRGF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09